NIH Guide: Weekly Index for April 3, 2020

Funding Opportunities

• Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
  (PA-20-162)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
  (PA-20-163)
  National Institutes of Health
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): See the competitive revision NOSI for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
  (PAR-20-152)
  National Eye Institute
  Application Receipt Date(s): April 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
  (PAR-20-153)
  National Institute of General Medical Sciences
  Application Receipt Date(s): July 14, 2020; July 13, 2021; July 13, 2022,by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  (PAR-20-154)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
  (PAR-20-155)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
• Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
  (PAR-20-156)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
  (PAR-20-157)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
• Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
  (PAR-20-158)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
  (PAR-20-159)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 16, 2020
• Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed)
  (PAR-20-161)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): September 14, 2020, March 17, 2021, March 17, 2022, March 17, 2023
• Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)
  (PAR-20-164)
  National Institute on Minority Health and Health Disparities
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 14, 2020, July 14, 2021, July 14, 2022
• Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
  (PAS-20-160)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Standard dates apply.
• Tuberculosis Research Units (U19 Clinical Trial Optional)
  (RFA-AI-20-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Acute Dental Pain (U01) Clinical Trials Not Allowed
  (RFA-FD-20-029)
  Food and Drug Administration
  Application Receipt Date(s): June 1, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Drug Development Science Support (U01) Clinical Trials Optional
  (RFA-FD-20-033)
  Food and Drug Administration
  Application Receipt Date(s): June 8, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed
  (RFA-FD-20-034)
  Food and Drug Administration
  Application Receipt Date(s): June 1, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional)
  (RFA-HD-21-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): August 14, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)
  (RFA-HD-21-017)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
  (RFA-NS-20-029)
  National Institute of Neurological Disorders and Stroke
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): July 14, 2020 and June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.